Clinical Trial

What is the Role of Triglyceride-glucose Index as a Predictive Marker for Insulin Resistance in Pre Diabetic Chronic Kidney Disease Patients?

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the role of the triglyceride-glucose (TyG) index as a predictive marker for insulin resistance in pre-diabetic patients with chronic kidney disease (CKD), and to investigate its potential utility as a simple, non-invasive alternative to traditional insulin resistance assessment methods.
Trial Details
NCT Number NCT07279922
Lead Sponsor Assiut University
Conditions Chronic Kidney Disease, Pre Diabetes
Enrollment 60 participants
Start Date 2026-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-12